HPSE2

protein-coding

heparanase 2 (inactive), the group of MicroRNA protein coding host genes|Heparanases

Gene summary

This gene encodes a heparanase enzyme. The encoded protein is a endoglycosidase that degrades heparin sulfate proteoglycans located on the extracellular matrix and cell surface. This protein may be involved in biological processes involving remodeling of the extracellular matrix including angiogenesis and tumor progression. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]

Previous symbols:
  • UFS

MANE transcript

NM_021828.5

Inheritance

AR

ClinVar variants

P:22U:148B:35

Top phenotype

Ochoa syndrome; Urofacial syndrome 1

gnomAD constraint

pLI —, LoF o/e 0.41

Max pathogenic AF

—

Genomic locus

chr10:98,457,077-99,235,862

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~778.8 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Ochoa syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0000463

Submitter: Orphanet

urofacial syndrome type 1MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0009368

Submitter: Ambry Genetics

urofacial syndrome type 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009368

Submitter: PanelApp Australia

urofacial syndrome type 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009368

Submitter: Labcorp Genetics (formerly Invitae)

urofacial syndrome type 1DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009368

Submitter: G2P

Clinical Genomic Database (CGD)

Ochoa syndrome; Urofacial syndrome 1AR

Manifestation: Craniofacial; Neurologic; Renal

Intervention: Renal

Rationale: Individuals are at high risk of infantile-onset vesicoureteral reflux leading to kidney damage, hypertension, and eventual renal failure, and surveillance and preventive measures related to manifestations such as urinary tract/renal infections may be beneficial

Refs: 11446407; 19839856; 19669792; 20560209; 20560210; 20605127; 21332471; 21450525Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to HPSE2 variants in ClinVar

8 Conditions Cataloged
Urofacial syndrome type 1Total: 100
not providedTotal: 98
Inborn genetic diseasesTotal: 87
HPSE2-related disorderTotal: 13
not specifiedTotal: 9
Ochoa syndromeTotal: 3
Congenital anomaly of kidney and urinary tractTotal: 2
HPSE2-related disordersTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_021828.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
29
clinvar
33
missense
1
clinvar
142
clinvar
5
clinvar
1
clinvar
149
nonsense
3
clinvar
2
clinvar
1
clinvar
6
start loss
0
frameshift
3
clinvar
7
clinvar
10
splice donor/acceptor (+/-2bp)
2
clinvar
4
clinvar
1
clinvar
7
Total913148341205

Highest pathogenic variant AF is 0.00041941786

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 22 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_021828.5RefSeqNP_068600.412MANE Select
ENST00000370552.8EnsemblENSP00000359583.312MANE Select
NM_001166244.1RefSeqNP_001159716.111Standard
NM_001166245.1RefSeqNP_001159717.110Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Proteoglycans in cancer - Homo sapiens (human)
  • Glycosaminoglycan degradation - Homo sapiens (human)
  • Metabolism of carbohydrates
  • HS-GAG degradation
  • Heparan sulfate/heparin (HS-GAG) metabolism

Biological Process

  • glycosaminoglycan catabolic process
  • biological_process
  • positive regulation of cell population proliferation
  • extracellular matrix organization

Molecular Function

  • heparanase activity
  • heparan sulfate proteoglycan binding

Cellular Component

  • plasma membrane
  • extracellular matrix

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000370552
Coding exons
12
Length
776745
Individuals with no LoFs
125670
Homozygous LoFs
0
Heterozygous LoFs
78
Defined
125748
p
0.000310
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.2453163290.9620.00001893822
Missense (PolyPhen)122135.080.903191580
Synonymous-0.8141441321.090.000006771224
Loss of Function2.791126.50.4150.00000136327

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000490.00049rare
Latino/Admixed American0.0000870.000087rare
Ashkenazi Jewish00.0absent
East Asian0.0000540.000054rare
Finnish0.0000950.000092rare
European (Non-Finnish)0.000520.00052rare
South Asian0.0000650.000065rare
Other0.000490.00049rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Binds heparin and heparan sulfate with high affinity, but lacks heparanase activity. Inhibits HPSE, possibly by competing for its substrates (in vitro). {ECO:0000269|PubMed:20576607}.;
Disease
DISEASE: Urofacial syndrome 1 (UFS1) [MIM:236730]: A rare autosomal recessive disorder characterized by facial grimacing when attempting to smile and failure of the urinary bladder to void completely despite a lack of anatomical bladder outflow obstruction or overt neurological damage. Affected individuals often have reflux of infected urine from the bladder to the upper renal tract, with a risk of kidney damage and renal failure. {ECO:0000269|PubMed:20560209, ECO:0000269|PubMed:20560210}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.185

Intolerance Scores

LoFtool
0.898
RVIS EVS
0.09
RVIS percentile EVS
60.57

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.303

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.